Bupivacaine, Epinefrina bitartrato

Bupivacaína/Adrenalina Physan 2,5 MG/ML + 0,005 MG/ML Solución Inyectable

25 mg + 0,05 mg solución inyectableSpainMarketedAuthorised 31 Mar 1968

Packs

Pack	Code	Status
BUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE, 50 ampollas de 10 ml	607375
BUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE, 100 ampollas de 10 ml	615930

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Bupivacaine, Epinefrina bitartrato

Bupivacaína/Adrenalina Physan 2,5 MG/ML + 0,005 MG/ML Solución Inyectable

25 mg + 0,05 mg solución inyectableSpainMarketedAuthorised 31 Mar 1968

Product informationAsk Osler about it

Packs

Pack	Code	Status
BUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE, 50 ampollas de 10 ml	607375
BUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE, 100 ampollas de 10 ml	615930

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Bupivacaine, Epinefrina bitartrato
Strength: 25 mg + 0,05 mg
Dosage form: solución inyectable
Route: vía epidural, vía intraarticular, vía intramuscular, vía perineural, vía subcutánea, uso perióseo, infiltración
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 Mar 1968
Registration: 45668
Marketing authorisation holder: Laphysan S.A.U.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario